Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Announces the NMPA Granted New Indication Approval for BYVASDA® (Bevacizumab Biosimilar) for the Treatment of Adult Recurrent Glioblastoma 2020-12-28 08:00
Arctic Vision obtains the first IND approval for the treatment of UME in China, Suprachoroidal space (SCS) injection potentially brings more benefits to patients 2020-12-25 21:00
INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet's EClinicalMedicine 2020-12-24 23:12
Foresee Pharmaceuticals Announces Completion of US$47 Million Financing 2020-12-24 18:00
Senhwa Biosciences Receives US FDA 'Study May Proceed' Letter to Treat BRCA2+ or PALB2+ Solid Tumors With CX-5461 2020-12-24 10:40
LycovaryTM Daily provides anti-ageing oxygenation of the ovaries to help women with PMS, painful periods and comfortable menopause transition 2020-12-24 08:00
Conbercept: New Generation of Product for Treatment of nAMD Completes 36-week Primary Endpoint Visits of Phase III Trial 2020-12-23 22:40
I-Mab Announces Upcoming Participation at January Conferences 2020-12-23 21:00
Innovent Announces NMPA Granted New Indication Approvals for SULINNO® (Adalimumab Injection) for the Treatment of Pediatric Plaque Psoriasis and Non-infectious Uveitis 2020-12-23 12:30
Hyundai Bioscience Develops Injection Drug for Potential Treatment of Severe Cases of COVID-19 2020-12-23 10:09
RedHill's Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Continue 2020-12-22 20:38
Overweight and Obese Subjects Dosed with ASC41 Tablets in a Phase Ib Trial 2020-12-22 19:18
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004 2020-12-21 23:00
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004 2020-12-21 23:00
LT1001 (Naldebain(R)), an Extended-Release Analgesic Injection, Received Its Second Approval from Singapore's HSA 2020-12-21 22:08
Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson's Progression Markers Initiative 2020-12-21 21:00
BioVaxys Vaccine Platform Stimulates Robust T-cell Response Against Viral Antigens 2020-12-21 21:00
ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate development of the treatment 2020-12-21 10:43
Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy 2020-12-21 08:00
Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration 2020-12-18 23:30
1 265 266 267 268 269 412